Planet Labs (PL) Rule 144 Notice — 169,694 Warrants to Trade
Rhea-AI Filing Summary
Form 144 notice for Planet Labs PBC (PL) reports a proposed sale of 169,694 warrants through Morgan Stanley Smith Barney LLC, with an aggregate market value of $339,727.39. The company’s total warrants outstanding are listed as 12,833,315. The filer states the securities were acquired as founder stock on 03/05/2021 from the issuer and paid in cash on the same date. The proposed approximate sale date is 09/12/2025 on the NYSE. Recent dispositions by ISALEA INVESTMENTS LP over the past three months are disclosed: sales on 08/19/2025 (10,000 warrants, $10,217.00), 06/13/2025 (3,800 warrants, $2,443.40) and 06/12/2025 (8,600 warrants, $5,849.72). The filer signs a standard representation that no undisclosed material adverse information is known.
Positive
- Full transaction details provided: class, acquisition date, broker, quantity, market value, and exchange are disclosed
- Recent prior sales disclosed: ISALEA INVESTMENTS LP transactions in June and August 2025 with gross proceeds listed
Negative
- Issuer contact and filer identification fields are incomplete or not provided in the content
Insights
TL;DR Proposed sale of 169,694 warrants valued at $339,727 on NYSE; prior small disposals by related investor are disclosed.
The filing documents a Rule 144 notice for the sale of warrants issued by the named issuer. The instruments were acquired as founder stock on 03/05/2021 and are intended to be sold via Morgan Stanley Smith Barney LLC with an approximate sale date of 09/12/2025. Recent sales by ISALEA INVESTMENTS LP totaling 22,400 warrants over the past three months are itemized with gross proceeds. The notice includes the required representation about lack of undisclosed material adverse information. No financial results, liquidity metrics, or additional corporate actions are provided in this filing.
TL;DR Routine insider/affiliate Rule 144 disclosure showing planned sale; standard certifications are included.
The form contains the customary certifications and transaction-level detail required under Rule 144: class, acquisition date, nature of acquisition, broker, quantities, and recent related-party sales. It confirms the securities were founder-stock acquired from the issuer and paid in cash. The filing does not disclose any material adverse information and does not present governance actions or changes. As a disclosure filing, its primary function is regulatory compliance rather than announcing strategic corporate events.